布鲁克代尔养老

最新新闻

• 评级变动
  Barclays Maintains Brookdale Senior Living(BKD.US) With Buy Rating, Maintains Target Price $15
  \u5e02\u573a\u8d44\u8baf · 2026/1/29
• 评级变动
  Barclays Maintains Brookdale Senior Living(BKD.US) With Buy Rating, Cuts Target Price to $17
  \u5e02\u573a\u8d44\u8baf · 2026/8/11
• 评级变动
  BofA Securities Maintains Brookdale Senior Living(BKD.US) With Buy Rating, Raises Target Price to $18
  \u5e02\u573a\u8d44\u8baf · 2026/2/2
• BofA Securities Maintains Brookdale Senior Living(BKD.US) With Buy Rating, Announces Target Price $19.5
  \u5e02\u573a\u8d44\u8baf · 2026/9/24
• 评级变动
  Barclays Maintains Brookdale Senior Living(BKD.US) With Buy Rating, Raises Target Price to $18
  \u5e02\u573a\u8d44\u8baf · 2026/2/3
• 评级变动
  Analysts Offer Insights on Healthcare Companies: Neurosense Therapeutics Ltd. (NRSN) and Brookdale Senior Living (BKD)
  TipRanks · 2026/8/11
• 评级变动
  RBC Capital Maintains Brookdale Senior Living(BKD.US) With Buy Rating, Raises Target Price to $17
  \u5e02\u573a\u8d44\u8baf · 2026/1/29
• 评级变动
  A Quick Look at Today's Ratings for Brookdale Senior Living(BKD.US), With a Forecast Between $17 to $23
  \u5e02\u573a\u8d44\u8baf · 2026/5/8
• Jefferies Maintains Brookdale Senior Living(BKD.US) With Buy Rating, Maintains Target Price $23
  \u5e02\u573a\u8d44\u8baf · 2026/9/17
• 评级变动
  BofA Securities Maintains Brookdale Senior Living(BKD.US) With Buy Rating
  \u5e02\u573a\u8d44\u8baf · 2026/8/12
• Barclays Maintains Brookdale Senior Living(BKD.US) With Buy Rating, Maintains Target Price $17
  \u5e02\u573a\u8d44\u8baf · 2026/9/10
• RBC Capital Maintains Brookdale Senior Living(BKD.US) With Buy Rating, Maintains Target Price $17
  \u5e02\u573a\u8d44\u8baf · 2026/9/10
• 评级变动
  Jefferies Maintains Brookdale Senior Living(BKD.US) With Buy Rating, Raises Target Price to $23
  \u5e02\u573a\u8d44\u8baf · 2026/2/21
• 评级变动
  BofA Securities Maintains Brookdale Senior Living(BKD.US) With Buy Rating, Raises Target Price to $19.5
  \u5e02\u573a\u8d44\u8baf · 2026/2/19
• 评级变动
  Analysts Offer Insights on Healthcare Companies: Brookdale Senior Living (BKD), Tempus AI, Inc. Class A (TEM) and Editas Medicine (EDIT)
  TipRanks · 2026/5/8
• 评级变动
  Barclays Maintains Brookdale Senior Living(BKD.US) With Buy Rating, Maintains Target Price $18
  \u5e02\u573a\u8d44\u8baf · 2026/7/9
• 评级变动
  BofA Securities Maintains Brookdale Senior Living(BKD.US) With Buy Rating, Raises Target Price to $15.5
  \u5e02\u573a\u8d44\u8baf · 2026/1/29
• BofA Securities Maintains Brookdale Senior Living(BKD.US) With Buy Rating, Maintains Target Price $19.5
  \u5e02\u573a\u8d44\u8baf · 2026/9/30
• 评级变动
  Compass Point Initiates Brookdale Senior Living(BKD.US) With Buy Rating, Announces Target Price $22
  \u5e02\u573a\u8d44\u8baf · 2026/6/15
• 评级变动
  Stephens Initiates Brookdale Senior Living(BKD.US) With Buy Rating, Announces Target Price $18
  \u5e02\u573a\u8d44\u8baf · 2026/5/9

新闻标题为自动聚合内容，未经我们团队独立核实或编辑。